Analysts say the adoption of GLP-1 drugs, the expansion of AI and the growth of multi-billion-dollar M&A deals chart an unpredictable path for the industry this year.

The Coors Light manufacturer’s 8.5% stake in the nonalcoholic carbonated mixer, worth $89 million, further builds on its long ...

Wells Fargo analyst Christopher Carey maintained a Buy rating on Molson Coors (TAP – Research Report) yesterday and set a price target of ...

Molson Coors Beverage Company has announced a strategic partnership with Fever-Tree in the US, aiming to fuel its ...

It’s been more than 30 years since Miller Lite beer had a nationally broadcast Super Bowl ad. But that changed in 2023 ...

Under President Donald Trump’s Project 2025, the administration has launched an unprecedented effort to dismantle diversity, ...

Sportico previously reported the team was acquired for a record $110 million expansion fee, more than twice what Boston's ...

The majority owner of the new National Women's Soccer League team in Denver says there are plans to build a dedicated soccer ...

Molson Coors Beverage Co. announced Thursday that it has acquired an 8.5% stake in Fevertree Drinks PLC, the British premium ...

By Shashwat Awasthi (Reuters) -Shares of Fevertree Drinks surged almost 24% after Molson Coors' took an 8.5% stake in the ...

The Coors Light brewer will pay £71 million ($88 million) for 8.5% of Fevertree, a move that will help the Chicago-based company expand its non-alcoholic range.

(Alliance News) - Fevertree Drinks PLC on Thursday said it intends to launch a share buyback programme for up to GBP71.0 million, on the back of a new partnership with Molson Coors Beverage Co for the ...